# Acute and Short-term Chronic Effects of Galvus (Vildagliptin) in Diabetes Type 2 Obese Women

> **NCT01827280** · PHASE4 · COMPLETED · sponsor: **Rio de Janeiro State University** · enrollment: 40 (actual)

## Conditions studied

- 1- Microvascular Function
- 2-oxidative Stress
- 3-inflammation

## Interventions

- **DRUG:** Vildagliptin

## Key facts

- **NCT ID:** NCT01827280
- **Lead sponsor:** Rio de Janeiro State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2016-08
- **Final completion:** 2016-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01827280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01827280, "Acute and Short-term Chronic Effects of Galvus (Vildagliptin) in Diabetes Type 2 Obese Women". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01827280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*